Pfizer Sells 700 Million Haleon Shares for $3 Billion
The sale decreases Pfizer’s shareholding in the consumer-healthcare business to 7.3% of its issued share capital, down from 15%.
Pfizer Sells 700 Million Haleon Shares for $3 Billion Read More »
Pfizer Sells 700 Million Haleon Shares for $3 Billion Read More »
DirecTV Pursues Sports Fans With New, Slimmer Streaming Bundle Read More »
Eli Lilly Cuts Sales Outlook After Sluggish Growth for Incretin Drugs Read More »
The Hottest Ticket Across Corporate America: Trump’s Inauguration Read More »
Cleveland-Cliffs and Nucor Mull Fresh Bid for U.S. Steel Read More »
Hanging Out at Starbucks? You Now Need to Order Something Read More »